Afrinayanti W. Siregar
Research Subjects
Afrinayanti W. Siregar has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- Cynthia Gozali
Division of Materials Science, Graduate School of Science and Technology, Nara Institute of Science and Technology, 8916-5 Takayama, Ikoma, Nara 630-0192, Japan
1 shared publication - Mirzan Hasibuan
Prof. Dr. Chairuddin Panusunan Lubis Universitas Sumatera Utara Teaching Hospital, Universitas Sumatera Utara, Medan 20155, Indonesia
1 shared publication - Raden Lia Kusumawati
Department of Microbiology, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia
1 shared publication
Latest Publications
- Open Access
- 1 June 2025
- Published by Journal of Pure and Applied Microbiology in Journal of Pure and Applied Microbiology
- Vol. 19 (2) , 1390-1400
Detection of Burkholderia pseudomallei in Suspected Melioidosis at Universitas Sumatera Utara (USU) Hospital, North Sumatra, Indonesia
Burkholderia pseudomallei, the causative agent of melioidosis, is endemic in Southeast Asia and tropical regions like Indonesia. This bacterium poses a challenge due to its uncommon and resistance to high-generation antibiotics. This study aims to detect B. pseudomallei in clinical samples from patients suspected of having melioidosis and to describe its clinical manifestations. A total of 118 clinical samples were collected and analyzed using Ashdown’s Selective Agar and routine bacteriological media, while the Vitek 2 Compact system was utilized for antibiotic identification and sensitivity testing. B. pseudomallei was detected in 9 (7.6%) samples, with the highest positivity rate in sputum at 6/59 (10.16%), followed by pus at 5.9% (1/17), pleural fluid at 10% (1/10), and bronchoalveolar lavage (BAL) at 4.5% (1/22). No B. pseudomallei growth was detected in blood and urine samples. Clinically, the positive cases exhibited symptoms akin to pulmonary tuberculosis in 3/9 (33%), combined hydropneumothorax and pulmonary TB in 2/9 (22%), and bilateral pleural effusions in 1/9 (11%). Other clinical presentations included a combination of bilateral pleural effusions and pulmonary TB, mediastinal pleural effusion with pulmonary TB and pneumonia, and burns on the soles of the feet. Antibiotic susceptibility testing revealed effective treatment options for ceftazidime, piperacillin-tazobactam, meropenem, and tigecycline. These findings highlight B. pseudomallei as a significant health concern in North Sumatra, emphasizing the need for improved diagnostic awareness and effective antimicrobial strategies to manage melioidosis cases.
- 1 June 2025
- Published by Journal of Pure and Applied Microbiology in Journal of Pure and Applied Microbiology
- Vol. 19 (2) , 1390-1400
Open AccessDetection of Burkholderia pseudomallei in Suspected Melioidosis at Universitas Sumatera Utara (USU) Hospital, North Sumatra, Indonesia
Burkholderia pseudomallei, the causative agent of melioidosis, is endemic in Southeast Asia and tropical regions like Indonesia. This bacterium poses a challenge due to its uncommon and resistance to high-generation antibiotics. This study aims to detect B. pseudomallei in clinical samples from patients suspected of having melioidosis and to describe its clinical manifestations. A total of 118 clinical samples were collected and analyzed using Ashdown’s Selective Agar and routine bacteriological media, while the Vitek 2 Compact system was utilized for antibiotic identification and sensitivity testing. B. pseudomallei was detected in 9 (7.6%) samples, with the highest positivity rate in sputum at 6/59 (10.16%), followed by pus at 5.9% (1/17), pleural fluid at 10% (1/10), and bronchoalveolar lavage (BAL) at 4.5% (1/22). No B. pseudomallei growth was detected in blood and urine samples. Clinically, the positive cases exhibited symptoms akin to pulmonary tuberculosis in 3/9 (33%), combined hydropneumothorax and pulmonary TB in 2/9 (22%), and bilateral pleural effusions in 1/9 (11%). Other clinical presentations included a combination of bilateral pleural effusions and pulmonary TB, mediastinal pleural effusion with pulmonary TB and pneumonia, and burns on the soles of the feet. Antibiotic susceptibility testing revealed effective treatment options for ceftazidime, piperacillin-tazobactam, meropenem, and tigecycline. These findings highlight B. pseudomallei as a significant health concern in North Sumatra, emphasizing the need for improved diagnostic awareness and effective antimicrobial strategies to manage melioidosis cases.